Kieran Wynne

4.1k citations
96 papers · 2.8k indexed · h-index 30
Topics
Platelet Disorders and Treatments (9 papers)Tryptophan and brain disorders (9 papers)Epigenetics and DNA Methylation (9 papers)

In The Last Decade

Kieran Wynne

91 papers receiving 2.7k citations

Peers

Kieran Wynne
Comparison fields: 5 of 131
  • Molecular Biology 1.7k
  • Immunology 369
  • Hematology 285
  • Oncology 258
  • Cancer Research 253
Replace Xiaoqian Ma with:
Xiaoqian Ma China
David J. Meyers United States
Yingxin Zhao United States
Ida Biunno Italy
Young‐Min Hyun South Korea
Masood Kamali‐Moghaddam Sweden
Yifeng Yang China
Antonio Iglesias Germany
Stephen D. Cederbaum United States
George W. Cox United States
Kieran Wynne relative to Xiaoqian Ma China Xiaoqian Ma's profile →
Citations per field
00.5×1.5×
Xiaoqian Ma · 1×
Citations per year

Countries citing papers authored by Kieran Wynne

Since Specialization
Citations

This map shows the geographic impact of Kieran Wynne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kieran Wynne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kieran Wynne more than expected).

Fields of papers citing papers by Kieran Wynne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kieran Wynne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kieran Wynne. The network helps show where Kieran Wynne may publish in the future.

Co-authorship network of co-authors of Kieran Wynne

This figure shows the co-authorship network connecting the top 25 collaborators of Kieran Wynne. A scholar is included among the top collaborators of Kieran Wynne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kieran Wynne. Kieran Wynne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 3
4 3
5 4
6 3
7 5
8 1
9 10
10 21
11 123
12 25
13 63
14 39
15 9
16 25
17 32
18 29
19 10
20 4

About Kieran Wynne

Kieran Wynne is a scholar working on Biological Psychiatry, Internal Medicine and Hematology, having authored 96 papers that have together received 2.8k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (9 papers), Tryptophan and brain disorders (9 papers) and Epigenetics and DNA Methylation (9 papers). The work is most often cited by research in Biological Psychiatry (138 citations), Hematology (285 citations) and Molecular Biology (1.7k citations). Kieran Wynne has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include Gerard Cagney, Patricia B. Maguire, David Cotter, Jane A. English, Melanie Föcking, Patrick Dicker, Giuliano Elia, Desmond J. Fitzgerald, Catherine Godson and Michael Scannell. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026